FIA
ATNM icon

FNY Investment Advisers’s Actinium Pharmaceuticals ATNM Stock Holding History

FNY Investment Advisers’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-67
Closed – – 714
2018
Q4 		$0 Hold
67
– – ﹤0.01% 679
2018
Q3 		$1K Hold
67
– – ﹤0.01% 767
2018
Q2 		$1K Buy
+67
New +$849 ﹤0.01% 886

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

FNY Investment Advisers's ATNM Position: Q1 2019 in Review

FNY Investment Advisers sold out of Actinium Pharmaceuticals (ATNM) in Q1 2019, closing a stake of 67 shares.

FNY Investment Advisers first reported a position in ATNM in Q2 2018 and held it in 3 quarters. The position peaked at $1K in Q3 2018. 43 funds tracked by Wall St. Rank hold ATNM as of Q1 2019.

  • FNY Investment Advisers reported no remaining Actinium Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 67 Actinium Pharmaceuticals shares in Q1 2019.
  • FNY Investment Advisers first reported a position in Actinium Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Actinium Pharmaceuticals position peaked at $1K in Q3 2018.
  • 43 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2019.

Based on FNY Investment Advisers's 13F filing for Q1 2019, filed 17 Apr 2019.